Risk factors for severe and critically ill COVID‐19 patients: a review

Y Gao, M Ding, X Dong, J Zhang, A Kursat Azkur… - Allergy, 2021 - Wiley Online Library
The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

COVID-19 and solid organ transplantation: a review article

Y Azzi, R Bartash, J Scalea, P Loarte-Campos… - …, 2021 - journals.lww.com
The coronavirus pandemic has significantly impacted solid organ transplantation (SOT).
Early in the outbreak period, transplant societies recommended suspending living kidney …

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

A Sattler, E Schrezenmeier, UA Weber… - The Journal of …, 2021 - Am Soc Clin Investig
Novel mRNA-based vaccines have been proven to be powerful tools in combating the
global pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) …

COVID–19 and chronic kidney disease: an updated overview of reviews

SS Jdiaa, R Mansour, A El Alayli, A Gautam… - Journal of …, 2022 - Springer
Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment

K El Karoui, AS De Vriese - Kidney International, 2022 - Elsevier
The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

[HTML][HTML] Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients

NB Yanay, S Freiman, M Shapira… - Kidney …, 2021 - kidney-international.org
The first emergency-use authorizations for COVID-19 vaccines were granted by the Food
and Drug Administration in December 2020, and clinical trials for the approval of more …

Early humoral responses of hemodialysis patients after COVID-19 vaccination with BNT162b2

C Speer, D Göth, L Benning, M Buylaert… - Clinical Journal of the …, 2021 - journals.lww.com
Results After the first vaccine dose, four of 22 (18%) patients on dialysis compared with 43 of
46 (93%) healthy controls developed positive anti-S1 IgG, with a median anti-S1 IgG index …

Antibody response to COVID-19 vaccination in patients receiving dialysis

S Anand, ME Montez-Rath, J Han… - Journal of the …, 2021 - journals.lww.com
Data from hepatitis B1 and influenza vaccination2 studies indicate blunted and
foreshortened response to immunization in patients receiving dialysis, raising the worrisome …

Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease: a systematic review and meta-analysis

JJ Chen, TH Lee, YC Tian, CC Lee, PC Fan… - JAMA network …, 2021 - jamanetwork.com
Importance Adults receiving dialysis treatment have a higher likelihood of death when
infected with SARS-CoV-2 than adults not receiving dialysis treatment. To date, the immune …

The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action

A Francis, C Baigent, TA Ikizler… - Kidney …, 2021 - kidney-international.org
The coronavirus disease 2019 (COVID-19) pandemic is causing extreme stress to many
health systems and an evermounting death toll. Out of the darkness of the last 14 months …